Achievement of combined goals of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol with three different statins: Results from VOYAGER
Authors:
- Björn W. KarlsonBKBjörn W. Karlson
- Peter P. TothPTPeter P. Toth
- Michael K. PalmerMPMichael K. Palmer
- Philip J. BarterPBPhilip J. Barter
- Stephen J. NichollsSNStephen J. Nicholls
Open Access
- 1 November 2014
- journal article
- Published by Elsevier in IJC Metabolic & Endocrine
- Vol. 5, 61-66
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 15 references indexed in Scilit:
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemiaJournal of Clinical Lipidology, 2013
- 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the AdultCanadian Journal of Cardiology, 2013
- Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin‐Treated Subjects From 3 Data Sources: A Retrospective AnalysisJournal of the American Heart Association, 2012
- Role of Non-High-Density Lipoprotein Cholesterol in Predicting Cerebrovascular Events in Patients Following Myocardial InfarctionThe American Journal of Cardiology, 2012
- Barriers to Non-HDL Cholesterol Goal Attainment by ProvidersThe American Journal of Medicine, 2011
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- ‘Trig-onometry’: non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemiaInternational Journal Of Clinical Practice, 2010
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease MortalityArchives of internal medicine (1960), 2001
- Rationale for Use of Non–High-Density Lipoprotein Cholesterol Rather Than Low-Density Lipoprotein Cholesterol as a Tool for Lipoprotein Cholesterol Screening and Assessment of Risk and TherapyThe American Journal of Cardiology, 1998